Shamyla Siddique

1.6k total citations
16 papers, 879 citations indexed

About

Shamyla Siddique is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, Shamyla Siddique has authored 16 papers receiving a total of 879 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 6 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Shamyla Siddique's work include Acute Myeloid Leukemia Research (11 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Histone Deacetylase Inhibitors Research (5 papers). Shamyla Siddique is often cited by papers focused on Acute Myeloid Leukemia Research (11 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Histone Deacetylase Inhibitors Research (5 papers). Shamyla Siddique collaborates with scholars based in United Kingdom, United States and India. Shamyla Siddique's co-authors include Charles Craddock, Paresh Vyas, Oliver Goodyear, Paul Moss, Gordon B. Ryan, Jamie Cavenagh, Ram Malladi, Mike Dennis, Angelo Agathanggelou and Igor Novitzky‐Basso and has published in prestigious journals such as Journal of Clinical Oncology, Blood and BMC Medical Research Methodology.

In The Last Decade

Shamyla Siddique

15 papers receiving 870 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shamyla Siddique United Kingdom 7 692 262 259 171 155 16 879
Leandro de Pádua Silva United States 9 572 0.8× 226 0.9× 120 0.5× 195 1.1× 84 0.5× 25 746
Marina Konopleva United States 13 532 0.8× 365 1.4× 52 0.2× 105 0.6× 156 1.0× 77 739
Susana Vives Spain 10 533 0.8× 272 1.0× 76 0.3× 231 1.4× 209 1.3× 37 791
Maria‐Cristina Sauerland Germany 8 1.1k 1.5× 688 2.6× 78 0.3× 294 1.7× 150 1.0× 10 1.2k
Joseph O. Moore United States 10 1.0k 1.5× 555 2.1× 177 0.7× 350 2.0× 181 1.2× 17 1.3k
Valentina Gianfelici Italy 15 312 0.5× 243 0.9× 113 0.4× 280 1.6× 168 1.1× 29 736
JH Bourhis United States 8 437 0.6× 151 0.6× 119 0.5× 59 0.3× 136 0.9× 10 507
Paulo Lúcio Portugal 13 469 0.7× 255 1.0× 144 0.6× 308 1.8× 160 1.0× 30 854
MV Mateos Spain 12 650 0.9× 261 1.0× 158 0.6× 163 1.0× 263 1.7× 37 750
Cecilia Sheen United States 6 280 0.4× 132 0.5× 176 0.7× 231 1.4× 120 0.8× 9 569

Countries citing papers authored by Shamyla Siddique

Since Specialization
Citations

This map shows the geographic impact of Shamyla Siddique's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shamyla Siddique with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shamyla Siddique more than expected).

Fields of papers citing papers by Shamyla Siddique

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shamyla Siddique. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shamyla Siddique. The network helps show where Shamyla Siddique may publish in the future.

Co-authorship network of co-authors of Shamyla Siddique

This figure shows the co-authorship network connecting the top 25 collaborators of Shamyla Siddique. A scholar is included among the top collaborators of Shamyla Siddique based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shamyla Siddique. Shamyla Siddique is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Loke, Justin, Aimee Jackson, Shamyla Siddique, et al.. (2023). Posttransplant MRD and T-cell chimerism status predict outcomes in patients who received allografts for AML/MDS. Blood Advances. 7(14). 3666–3676. 21 indexed citations
2.
Malladi, Ram, Ikhlaaq Ahmed, Graham McIlroy, et al.. (2021). Azacitidine for the treatment of steroid-refractory chronic graft-versus-host disease: the results of the phase II AZTEC clinical trial. Bone Marrow Transplantation. 56(12). 2948–2955.
3.
4.
Craddock, Charles, Daniel Slade, Carmela De Santo, et al.. (2019). Combination Lenalidomide and Azacitidine: A Novel Salvage Therapy in Patients Who Relapse After Allogeneic Stem-Cell Transplantation for Acute Myeloid Leukemia. Journal of Clinical Oncology. 37(7). 580–588. 51 indexed citations
5.
6.
Brock, Kristian, et al.. (2017). Implementing the EffTox dose-finding design in the Matchpoint trial. BMC Medical Research Methodology. 17(1). 112–112. 19 indexed citations
7.
8.
Craddock, Charles, Shamyla Siddique, Christina Yap, et al.. (2015). Tolerability and Clinical Activity of Post-Transplantation Azacitidine in Patients Allografted for Acute Myeloid Leukemia Treated on the RICAZA Trial. Biology of Blood and Marrow Transplantation. 22(2). 385–390. 128 indexed citations
9.
10.
Goodyear, Oliver, Mike Dennis, Justin Loke, et al.. (2012). Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML). Blood. 119(14). 3361–3369. 301 indexed citations
11.
12.
Craddock, Charles, Nicolas Goardon, Lynn Quek, et al.. (2011). Quantitation of Leukemic Stem Cell Populations Predicts Clinical Outcome in Acute Myeloid Leukaemia. Blood. 118(21). 638–638. 1 indexed citations
13.
Goodyear, Oliver, Angelo Agathanggelou, Igor Novitzky‐Basso, et al.. (2010). Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia. Blood. 116(11). 1908–1918. 265 indexed citations
14.
Craddock, Charles, et al.. (2009). 5 ' AZACITIDINE IN COMBINATION WITH VALPROIC ACID INDUCES COMPLETE REMISSIONS IN PATIENTS WITH HIGH RISK ACUTE MYELOID LEUKAEMIA BUT DOES NOT ERADICATE CLONAL LEUKAEMIC STEM/PROGENITOR CELLS. Oxford University Research Archive (ORA) (University of Oxford). 94. 429–429. 2 indexed citations
15.
16.
Olavarría, Eduardo, Shamyla Siddique, Mike Griffiths, et al.. (2007). Posttransplantation imatinib as a strategy to postpone the requirement for immunotherapy in patients undergoing reduced-intensity allografts for chronic myeloid leukemia. Blood. 110(13). 4614–4617. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leandro de Pádua Silva Breakdown of academic impact, for papers by Marina Konopleva Breakdown of academic impact, for papers by Susana Vives Breakdown of academic impact, for papers by Maria‐Cristina Sauerland Breakdown of academic impact, for papers by Joseph O. Moore Breakdown of academic impact, for papers by Valentina Gianfelici Breakdown of academic impact, for papers by JH Bourhis Breakdown of academic impact, for papers by Paulo Lúcio Breakdown of academic impact, for papers by MV Mateos Breakdown of academic impact, for papers by Cecilia Sheen
Rankless by CCL
2026